Related Experiment Videos
Melancholia with onset during treatment with SSRIs
1Department of Psychiatry, East Tennessee State University, Johnson City, USA. ectdoc@pol.net
Summary
Patients on SSRI antidepressants who develop melancholic depression may respond well to alternative treatments. Bupropion, nortriptyline with triiodothyronine, or electroconvulsive therapy (ECT) showed rapid remission in nine cases.
Area of Science:
- Psychiatry
- Neuroscience
- Pharmacology
Background:
- Major depression with melancholic features is a subtype of depression.
- Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed antidepressants.
- Melancholic depression has been reported to have low responsiveness to SSRIs.
Purpose of the Study:
- To investigate treatment outcomes for patients developing melancholic depression while on SSRI antidepressants.
- To identify effective alternative treatments for SSRI-induced melancholic depression.
Main Methods:
- A retrospective survey of medical records was conducted.
- Nine cases of patients developing melancholic depression during SSRI treatment were identified.
- Treatment responses to bupropion, nortriptyline with triiodothyronine, and electroconvulsive therapy (ECT) were analyzed.
Main Results:
- All nine patients were taking SSRIs when melancholic depression onset occurred.
- Rapid remission was observed with the first treatment initiated.
- Five males responded to bupropion.
- Two females responded to nortriptyline with triiodothyronine.
- One male and one female responded to ECT.
Conclusions:
- Patients experiencing melancholic depression while on SSRIs may benefit from bupropion, nortriptyline with triiodothyronine, or ECT.
- These findings support the distinction between melancholic and nonmelancholic depressions.
- Alternative antidepressant strategies are suggested for SSRI non-responders with melancholic features.